India.com News Desk | Jan 25, 2022, 11:55 PM IST
Apart from Cyrus Poonawalla, other recipients of the prestigious award include Krishna Ella and Suchitra Ella of Bharat Biotech. The awards were announced on the eve of Republic Day.
India.com News Desk | Jan 14, 2022, 7:16 AM IST
The Drugs Controller General of India (DCGI) on Friday will review applications filed by Bharat Biotech and Serum Institute of India for full market approval of its respective COVID vaccines - Covaxin and Covishield, sources said.
India.com News Desk | Jan 13, 2022, 10:12 PM IST
Issuing a statement, Bharat Biotech said the goals of developing a global vaccine against COVID-19 have been achieved.
India.com News Desk | Jan 12, 2022, 6:46 PM IST
To recall, the government had issued similar guidelines, the Centre said that patients with mild symptoms can get discharged after seven days of testing positive and having experienced no fever for three successive days.
India.com News Desk | Jan 12, 2022, 5:46 PM IST
The booster dose of Covaxin has shown to "neutralize" both Omicron and Delta variants of COVID-19, Bharat Biotech said in a statement on Wednesday.
ANI Feeds | Jan 8, 2022, 11:55 PM IST
The Hyderabad-based Bharat Biotech announced the results on the safety and immunogenicity of Covaxin (BBV152), a whole-virion inactivated COVID-19 vaccine as a booster dose.
India.com News Desk | Jan 8, 2022, 9:59 PM IST
The COVID-19 vaccination for those aged 15 to 18 years started in the country from January 3, 2022.
Nikhil Khattar | Jan 6, 2022, 7:41 PM IST
Most of the people are taking three paracetamol 500mg along with the Covaxin. Now a statement was released by Bharat Biotech on wednesday, no painkiller or paracetamol is recommended after Covaxin.
India.com News Desk | Jan 5, 2022, 6:09 PM IST
Prime Minister Narendra Modi had recently announced that the precautionary dose will be rolled out for the citizens from 10 January for healthcare workers, frontline workers and people above the age of 60 with comorbidities.
India.com News Desk | Jan 3, 2022, 4:14 PM IST
Third Dose Can Give Big Boost To Vaccine Effectiveness Against Omicron, Reveals Study
PTI | Dec 30, 2021, 7:31 PM IST
Bharat Biotech said announced its COVID vaccine Covaxin has proven to be safe, well-tolerated, and immunogenic in children in Phase 2 and Phase 2 trials.
India.com News Desk | Dec 27, 2021, 12:30 AM IST
The Drugs Controller General of India (DCGI) granted emergency use authorisation to indigenously-developed Covaxin for children above 12 years with certain conditions on Friday.
English
